Trialcentralnet Trademark Details

Trialcentralnet was registered on Tuesday, February 16, 2016 and is currently owned by Tcn Technologies, LLC under the registration number 4900043 . This mark is alive with a status of Registered. The last case file activity for this mark occured 8 years ago on Tuesday, February 16, 2016, according to the United State Patent & Trademark Office
Word Mark Trialcentralnet
Status Alive Registered 700 — Registered

Current Owner

Tcn Technologies, LLC of Needham, MA

View all trademarks for Tcn Technologies, LLC
Other Trademarks for Tcn Technologies, LLC

Previous Owners

Bbk Holdings, LLC of Newton, MA

View all trademarks for Bbk Holdings, LLC
Other Trademarks for Bbk Holdings, LLC
Serial Number 85802799
Registration Number 4900043
Status Date Tuesday, February 16, 2016
Filing Date Tuesday, February 16, 2016
Registration Date Tuesday, February 16, 2016
Attorney Thomas F. Dunn

Correspondent

THOMAS F DUNN
MORSE BARNES-BROWN & PENDLETON PC
230 THIRD AVENUE CITY POINT, 4TH FLOOR
WALTHAM, MA 02451

Case File Statements

Goods & Services Business consulting and management in the field of clinical trials, namely, providing information management services
Pseudo Mark Trial Central Net

Classifications

International Class Codes
035 — Class 35 includes mainly services rendered by persons or organizations principally with the object of: 1. help in the working or management of a commercial undertaking, or 2. help in the management of the business affairs or commercial functions of an industrial or commercial enterprise, as well as services rendered by advertising establishments primarily undertaking communications to the public, declarations or announcements by all means of diffusion and concerning all kinds of goods or services.
U.S. Class Codes 100, 101, 102
Status 6 — Active
Status Date Wednesday, January 2, 2013
First Use Anywhere Friday, January 1, 1999
First Use In Commerce Friday, January 1, 1999
Primary Code 035

You must be signed in to print.

Once signed in, look for the PDF button.